Welcome to the Survey of Key Informants' Patients (SKIP) program website!

Washington University in St. Louis is a world-renowned, top-ranked research institute* at the forefront of research examining the misuse and abuse of scheduled opioid drugs.

The rapid increase of prescription opiate abuse over the past 15 years has led to a national health concern that is only just beginning to be understood. Our program strongly believes the participation of substance abuse treatment facilities throughout the country is crucial to monitoring the incidence of abuse of prescription opiates, in addition to providing essential information about the characteristics, environments and underlying factors related to this issue.

Our goals are that through this research, we will not only be in a better position to develop more effective treatment programs, but will also facilitate preventative measures, educational tools and federal regulations. Together our goals will converge on one important over-riding issue: to reduce the rates of prescription opioid misuse and abuse and its negative effects on society.

I encourage you to explore the information on our website to determine if you or your facility may be interested in assisting us with this important research and become a participating member of the SKIP program.


Dr. Theodore J. Cicero, PhD
Professor, Vice-Chairman for Research
Department of Psychiatry
Washington University in St. Louis, School of Medicine

*Ranked #4 in US News and World Report, Best Research Medical Schools, 2010.


News Feed
1/1/2019: SKIP US Questionnaire V30a implemented.


For questions, comments or concerns, contact us at KeyInformants@psychiatry.wustl.edu.